Outcomes following I-131 treatment with cumulative dose exceeding or equal to 600 mCi in differentiated thyroid carcinoma patients

To evaluate treatment outcomes following radioactive iodine (RAI) treatment with a cumulative dose of ≥≥600 mCi in differentiated thyroid carcinoma (DTC) patients, a retrospective review of medical records was done in 176 DTC patients with a cumulative dose of ≥600 mCi from January 1993 to December...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaewput, Chalermrat, Pusuwan, Pawana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034781/
https://www.ncbi.nlm.nih.gov/pubmed/33850490
http://dx.doi.org/10.4103/wjnm.WJNM_49_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034781/
https://www.ncbi.nlm.nih.gov/pubmed/33850490
http://dx.doi.org/10.4103/wjnm.WJNM_49_20

Ejemplares similares